Filipa Lynce

Bone-Modifying Agents in Early-Stage and Advanced Breast Cancer

F. Lynce, A. Heeke, M. R. Nunes, 2018, Current Breast Cancer Reports.

Genomic Disparities in Breast Cancer Among Latinas.

S. Vadaparampil, K. Graves, C. Ricker, 2016, Cancer control : journal of the Moffitt Cancer Center.

Differences in Uptake of Risk Reduction Strategies Among Underserved Populations

K. Graves, F. Lynce, Filipa Lynce, 2015, EBioMedicine.

Racial Disparities in the Molecular Landscape of Cancer.

E. Heath, E. Obeid, A. Vanderwalde, 2018, Anticancer research.

First-in-human study of REGN3767 (R3767), a human LAG-3 monoclonal antibody (mAb), ± cemiplimab in patients (pts) with advanced malignancies.

K. Kelly, Melissa L. Johnson, Huanyu Chen, 2019, Journal of Clinical Oncology.